ICO
Closing Date:

Therapeutic Discovery for Laminopathies

Header

A leading biotechnology company with a focus on rare disease therapeutics is seeking academic institutions or industry partners who are performing therapeutic discovery in the area of laminopathies, with a particular interest in Dilated Cardiomyopathy (DCM). The team is seeking therapeutic hypotheses, drug targets and novel modalities that can address more than one organ dysfunction (e.g. heart, brain, skeletal muscle).

Approaches of Interest:

  • Therapeutics addressing organ dysfunction associated with all types of laminopathies
  • Approaches targeting genes...

Opportunity types being sought:

  • Technology

  • Academic Researcher

  • Centre of Excellence

  • Research Project

  • Spinout Company

  • Biotech Asset

To see the full details and submit your response please register now.

Benefits of registration:

  • Receive updates on the latest industry calls
  • Quickly and easily respond to calls via your dashboard
  • Build your academic profile
Powered ByInpart
An online matchmaking platform for university-industry collaboration. Learn More

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.